Dentsply Sirona Inc (XRAY)
27.80
-0.45
(-1.59%)
USD |
NASDAQ |
May 08, 12:18
Dentsply Sirona Cash from Financing (Quarterly): -14.00M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -14.00M |
| December 31, 2023 | -128.00M |
| September 30, 2023 | -109.00M |
| June 30, 2023 | -87.00M |
| March 31, 2023 | 17.00M |
| December 31, 2022 | -161.00M |
| September 30, 2022 | -6.00M |
| June 30, 2022 | -152.00M |
| March 31, 2022 | -10.00M |
| December 31, 2021 | -122.00M |
| September 30, 2021 | -179.00M |
| June 30, 2021 | -25.00M |
| March 31, 2021 | -53.00M |
| December 31, 2020 | -15.00M |
| September 30, 2020 | -37.00M |
| June 30, 2020 | 658.00M |
| March 31, 2020 | -130.00M |
| December 31, 2019 | -101.70M |
| September 30, 2019 | -160.80M |
| June 30, 2019 | -110.30M |
| March 31, 2019 | -99.20M |
| December 31, 2018 | -78.80M |
| September 30, 2018 | -82.40M |
| June 30, 2018 | -69.40M |
| March 31, 2018 | -19.40M |
| Date | Value |
|---|---|
| December 31, 2017 | -232.20M |
| September 30, 2017 | -22.10M |
| June 30, 2017 | -78.90M |
| March 31, 2017 | -67.60M |
| December 31, 2016 | -112.70M |
| September 30, 2016 | 237.10M |
| June 30, 2016 | -177.80M |
| March 31, 2016 | -472.80M |
| December 31, 2015 | -8.90M |
| September 30, 2015 | -55.50M |
| June 30, 2015 | -138.00M |
| March 31, 2015 | -100.50M |
| December 31, 2014 | -71.90M |
| September 30, 2014 | -90.86M |
| June 30, 2014 | -117.97M |
| March 31, 2014 | -55.48M |
| December 31, 2013 | -37.05M |
| September 30, 2013 | -109.21M |
| June 30, 2013 | -29.04M |
| March 31, 2013 | 13.60M |
| December 31, 2012 | -110.02M |
| September 30, 2012 | -78.17M |
| June 30, 2012 | -55.03M |
| March 31, 2012 | -12.38M |
| December 31, 2011 | -79.57M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-179.00M
Minimum
Sep 2021
658.00M
Maximum
Jun 2020
-46.29M
Average
-94.35M
Median
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 1.569B |
| Biolase Inc | 0.885M |
| Milestone Scientific Inc | 2.567M |
| Wellness Center USA Inc | 0.275M |
| Envista Holdings Corp | -2.60M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 25.00M |
| Cash from Investing (Quarterly) | -43.00M |
| Free Cash Flow | 279.00M |
| Free Cash Flow Per Share (Quarterly) | -0.0432 |
| Free Cash Flow to Equity (Quarterly) | 19.00M |
| Free Cash Flow to Firm (Quarterly) | 0.871M |
| Free Cash Flow Yield | 4.76% |